Equitable Trust’s Accolade Inc ACCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-163,731
Closed -$1.14M 478
2025
Q1
$1.14M Buy
163,731
+8,711
+6% +$58.3K 0.06% 203
2024
Q4
$530K Hold
155,020
0.03% 308
2024
Q3
$597K Hold
155,020
0.04% 276
2024
Q2
$555K Hold
155,020
0.04% 277
2024
Q1
$1.62M Hold
155,020
0.11% 143
2023
Q4
$1.86M Hold
155,020
0.14% 126
2023
Q3
$1.64M Hold
155,020
0.14% 127
2023
Q2
$2.09M Hold
155,020
0.16% 117
2023
Q1
$2.23M Hold
155,020
0.18% 108
2022
Q4
$1.21M Hold
155,020
0.1% 163
2022
Q3
$1.77M Hold
155,020
0.15% 131
2022
Q2
$1.15M Hold
155,020
0.09% 162
2022
Q1
$2.72M Hold
155,020
0.17% 114
2021
Q4
$4.09M Buy
+155,020
New +$5.08M 0.25% 92

Other funds holding ACCD

Equitable Trust's ACCD Position: Q2 2025 in Review

Equitable Trust sold out of Accolade Inc (ACCD) in Q2 2025, closing a stake of 163,731 shares — an estimated $1.14M sold.

Equitable Trust first reported a position in ACCD in Q4 2021 and held it in 14 quarters. The position peaked at $4.09M in Q4 2021. 1 fund tracked by Wall St. Rank holds ACCD as of Q2 2025.

  • Equitable Trust reported no remaining Accolade Inc position as of Q2 2025 after selling out during the quarter.
  • Equitable Trust sold 163,731 Accolade Inc shares in Q2 2025, an estimated $1.14M.
  • Equitable Trust first reported a position in Accolade Inc in Q4 2021 and held it in 14 quarters.
  • Equitable Trust's Accolade Inc position peaked at $4.09M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Accolade Inc as of Q2 2025.

Based on Equitable Trust's 13F filing for Q2 2025, filed 23 Jul 2025.